A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing-Reference-Cited by-同舟云学术

A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing

Published:2018-04-02 Issue:5 Volume:59 Page:1704
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Prasanna Ganesh¹,Ferrara Luciana¹,Adams Christopher²,Ehara Takeru²,Li Byron¹,Yang Louis¹,Xiang Chuanxi¹,Ng Christopher Thow Hing³,Kim Sean⁴,Towler Christopher⁵,Topley Todd⁵,McAllister Cale⁵,Ghosh Malay⁵,Newton Ronald⁶,Stacy Rebecca⁷,Rice Dennis S.¹,Mogi Muneto²

Affiliation:

1. Ophthalmology Research, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

2. Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

3. Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

4. Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

5. Technical Research & Development, Global Drug Development, Fort Worth, Texas, United States

6. Preclinical Safety, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

7. Translational Medicine, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts;Cells;2024-02-18

2. Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases;Frontiers in Pharmacology;2023-12-20

3. Advances in understanding glaucoma pathogenesis: A multifaceted molecular approach for clinician scientists;Molecular Aspects of Medicine;2023-12

4. Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness;Experimental Eye Research;2023-07

5. Toxicokinetics in preclinical drug development of small‐molecule new chemical entities;Biomedical Chromatography;2022-12-13